BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Vaxine

Vaxine logo

Founded
2002
Patents
10
Publications
89

Technologies

AI Companies (Drug Discovery)

Vaxine Pty Ltd is a rapidly growing Australian biotechnology company based in Adelaide that has developed an impressive pipeline of vaccines against infectious disease, allergy, and cancer. Vaxine has developed the Advax range of proprietary polysaccharide adjuvants and is currently applying this state of the art adjuvant technology to the development of vaccines against hepatitis B, pandemic influenza, Japanese encephalitis, West Nile virus, malaria, HIV and rabies, amongst others.

Become a Member to view additional information about this company